Fidelity International’s Day One Biopharmaceuticals DAWN Stock Holding History

Fidelity International’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,131,907	Closed	-$88.6M	–	1162
2026 Q1	$88.6M	Buy	+4,131,907	New	+$58.2M	0.07%	256

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fidelity International's DAWN Position: Q2 2026 in Review

Fidelity International sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 4,131,907 shares — an estimated $88.6M sold.

Fidelity International first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $88.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Fidelity International reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fidelity International sold 4,131,907 Day One Biopharmaceuticals shares in Q2 2026, an estimated $88.6M.
Fidelity International first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Fidelity International's Day One Biopharmaceuticals position peaked at $88.6M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.